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in some animal models, notably the rat, preoperative administration ofdonor
strain blood is sufficient to produce long-term renal allograft survival, even in
the absenceofadjunctive immunosuppression (1, 2). The mechanisms underlying
this enhancing effect are unclear, and interpretation ofrelevant experiments is
made difficult by the complexity of the rejection response and controversy about
the relative importance ofthe different cellular effectors (cytotoxic T cells and
delayed-type hypersensitivity [DTH]l responses) (3, 4). Possible mechanisms of
enhancement include the elimination (5) or clonal deletion (6) of alloreactive
lymphocytes, removal of passenger leukocytes (7), blocking of effector cells by
antibody or antigen, and in particular, the induction of alloantigen-specific
suppressor cells (or factors) (8-10).
In the rat, renal allografts undergoing unmodified rejection are characterized
bya progressiveand heterogeneousmononuclearcell infiltrate (11)and a striking
increase within the rejecting graft of donor class I and class II MHC antigen
expression (12). These events are closely related because the induction of MHC
antigens is mediated, at least in part, by products (notably IFN-y-a potent
inducer of both class I and class II MHC antigens) (13, 14) released from
activated infiltrating cells whereas the distribution and density of MHC expres-
sion may influence the vulnerability of the graft to the effector responses (4).
In this report we show that, although preoperative administration of donor
strain whole blood increases rat renal allograft survival, it results in a rapid
disappearance of graft interstitial dendritic cells and, paradoxically, an acceler-
ated cellular infiltration of the graft. The levels of alloantigen-specific and
-nonspecific cytotoxicity produced by splenocytes and graft infiltrating cells are
comparable in both transfused and unmodified recipients. In addition, enhanced
grafts unexpectedly show an accelerated and substantial induction, not only of
donor class I but also of class II MHC antigens. These findings suggest that
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preoperative blood transfusion causes sensitization of the recipient resulting in
an accelerated immunological response to the allograft that is, nevertheless,




Inbred male rats of the DA (RTI') and PVG (RT1°) strains were obtained
from OLAC Ltd. (Bicester, Oxon, England) and used when 8-16 wk old.
Kidney Transplantation.
￿
Kidneys from DA strain donors were transplanted into the
left orthotopic site of PVG recipients with end-to-end anastomosis of the renal artery,
renal vein, and ureter (15). The procedure was performed under chloral hydrate anes-
thesia and ischemia times were ^"25 min . Except where otherwise stated, the right kidney
of the recipient was left in situ. Rats in the transfused groups received 1 ml of heparinized
donor strain whole blood i.v. 7 d before transplantation.
Antibodies. The following mouse mAbs were used to identify rat leukocytes: MRC
OX-1 (leukocyte common antigen [16]), MRC OX-8 (T cytotoxic/suppressor cells [Tc/s]
and NK cells [17-19]), W3/25 (T helper cells [Th] and some macrophages [20, 21 ]), MRC
OX-19 (pan T cell determinant [18]), W3/13 (T cells, neutrophils and plasma cells [22])
and MRC OX-39 (leukocytes expressing IL-2 receptor). MRC OX-39 is a mouse IgGI
antibody, raised against rat T blasts, that recognizes the IL-2 receptor on the basis that it
immunoprecipitates a protein ofA 45,000 nonreduced and 50,000 reduced, and inhibits
pure IL-2 from binding to T blasts (Jefferies, W. A., D. J. Paterson, J. R. Green, M. R.
Brandon, P. Corthesy, M. Puklavec, and A. F. Williams, manuscript in preparation). MRC
OX-21 (human C3b inactivator [23]) was used as a negative control throughout. The
following mAbs identified monomorphic MHC class I and II determinants: MRC OX-18
(rat MHC class I antigens [24]) and MRC OX-6 (rat MHC class 11 I/A antigen [24]).
These antibodies were a kind gift of Dr. D. W. Mason and Dr. A. F. Williams (MRC
Cellular Immunology Unit, Oxford). In addition, mAbs used to distinguish between donor
and recipient MHC class I and II antigens were: MN4-91-6 (NDS 54), which reacts with
a polymorphic determinant of MHC class I present in DA but not PVG strain rats (25),
and F17-23-2, which reacts with a polymorphic determinant of MHC class II I/A antigen
present in DA but not PVG rats (25, 26) . These antibodies were a kind gift of Professor
J . Fabre, Blond McIndoe Centre for Medical Research, East Grinstead, Sussex .
Immunohistology.
￿
Kidney tissue was snap frozen in liquid nitrogen and cryostat sections
(5 gym) were cut at -20 ° C onto gelatinized slides. A range of monoclonal antibodies was
used to label the slides using a two-layer immunoperoxidase technique (21).
Quantitative Analysis ofCellular Infiltrate.
￿
The area ofeach immunoperoxidase-labeled
tissue section infiltrated by leukocytes of a particular phenotype was determined by
morphometric analysis using the point-counting technique (27, 28). Sections were exam-
ined at a magnification of 400 in the presence of a microscope eyepiece graticule engraved
with a squared grid bearing either 121 intersections (1 mm apart) or 745 intersections
(0.5 mm apart). For each high power field, the number of positively stained cells
superimposed by an intersection was counted and the area of the field occupied by cells
of a particular phenotype was calculated as: percent area of infiltrate = 100 x (number
of positive grid intersections)/(total number of grid intersections). All sections stained
with MRC OX-8, W3/25, MRC OX-19, W3/13, and MRC OX-39 were counted using a
745-point graticule, as were some sections stained with MRC OX-1 or a mixture of MRC
OX-8 and W3/25. However, in the latter two cases, slides with very heavy infiltrates were,
for convenience, counted using the 121-point graticule. For all sections, the total number
of points observed was well in excess of that required to maintain the accuracy of the
point-counting technique (27). All slides were assessed by two observers who had no prior
knowledge of the time point or the group from which the kidney had been harvested.
Each observer counted 10 adjacent high power fields of the kidney cortex and the results
were expressed as the mean ofthe results ofthe two observers. There was close agreement
between the two observers for all the antibodies used as shown by the correlation
coefficient (r) and by the mean percent difference (D) between the two observers, whereARMSTRONG ET AL.
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D = 100 X [(area infiltrate, observer A) - (area infiltrate, observer B)]/ [(area infiltrate,
observer A) + (area infiltrate, observer B)] . Values of r and D for individual antibodies
were as follows : MRC OX-1, r = 0.99, D = 6 .7% ; MRC OX-8, r = 0.98, D = 10.9% ;
W3/25, r= 0.85,D= 16.0% ; MRC OX-19, r= 0.93, D= 14.3% ; W3/13, r = 0.95, D=
8.6% ; MRC OX-39, r = 0.97, D = 15% and (OX8 + W3/25), r = 0.98, D = 11 .1%.
Because no attempt was made by the two observers to count the same area of the tissue
section, the close correlation between two observers indicated that the area counted was
representative of the whole section .
Harvesting of Graft Infiltrating Cells.
￿
Infiltrating mononuclear cells were harvested
from kidney allografts using enzyme digestion (hyaluronidase and collagenase) as previ-
ously described (29) .
Cytotoxicity Assays .
￿
Graft infiltrating cells and spleen cells from transplanted recipients
were tested for alloantigen-specific cytotoxicity and nonspecific cytotoxicity using a
standard 6-h Cr-release assay essentially as described elsewhere (29) . Alloantigen-specific
cytotoxicity was assessed using "Cr-labeled DA (RT1') Con A-transformed splenic blasts
as targets and nonspecific cytotoxicity was assessed using the rat myeloma Y3 (30), which
has the RT1° MHC genotype and is susceptible to NK activity . Specific "Cr release =
100 X [(experimental release) - (spontaneous release)]/[(maximum release) - (sponta-
neous release)] . Data shown are the means of quadruplicate determinations (SD <5% ;
spontaneous release <20% ofmaximum release in all experiments) .
Kidney Homogenates .
￿
The methods used for preparation of tissue homogenates and
quantitative analysis ofMHC antigens were essentially those of Milton et al . (12) . Homog-
enates were prepared from normal DA kidneys, and from DA renal allografts from both
enhanced and untreated recipients . Kidneys were excised, snap frozen in liquid nitrogen,
crushed, and stored as powder at -70'C . Homogenates were prepared by pooling five
kidneys in each group for each study day and mechanically homogenising them with a
Teflon pestle at 4°C in the presence of Tris-buffered saline containing 5 mM EDTA, 2
mM phenylmethylsulfonyl fluoride, and 2.5 mM iodoacetamide to inhibit proteolysis . The
washed homogenates were frozen at -70'C until use .
Quantitative Analysis ofDonor Class IMHCAntigens.
￿
80 Al of tripling dilutions of each
kidney homogenate were incubated with 80 Al of a predetermined dilution of donor-
specific anti-class I antibody MN4-91-6 representing conditions of target antigen excess
in the assay system . After incubation for 1 h at 4°C the supernatants were assayed for the
presence ofunbound antibody using an indirect radioactive binding assay (31) . Duplicate
25-Al samples of supernatant were incubated with 25 A1 of DA erythrocytes at 109/ml
(class I target) for I h at 4°C, which were then washed twice and incubated with 100 A1
of 1251-labeled sheep anti-mouse F(ab') 2 (Amersham International, Aylesbury, UK) at
saturating concentrations for 1 h at 4 °C . The cells were then washed and the cell bound
radioactivity measured in a gamma counter (LKB Instruments, London) .
Quantitative Analysis ofDonor Class II MHC Antigens .
￿
The donor-specific anti-class II
antibody F 17-23-2 was unsuitable for absorption analysis because, although it worked well
for immunohistologic analysis, its affinity did not appear to be sufficient to prevent high
free antibody concentrations even in the presence of antigen excess in the absorption
analysis (25) . Instead, polyspecific PVG anti-DA spleen serum was the source of anti-
class II antibodies, and the specificity of the assay derived from the use of purified DA
class II (I/A) MHC antigen as the target . As in the class I analysis, tripling dilutions of
kidney homogenates were incubated with a predetermined dilution of antibody, in this
case the polyspecific PVG anti-DA spleen serum . After incubation for 1 h at 4 °C, the
supernatants were assayed for the presence of unbound anti-DA class II antibody using
a radioactive binding assay . 25-,u1 samples of supernatants were placed in 96-well polyvinyl
chloride (PVC) plates (Dynatech, Billingshurst, Sussex), which had been previously coated
with the purified DA class II antigen . After incubation for 1 h the wells were washed and
incubated for a further 1 h with 50 A1 of 1251-labeled rabbit F(ab')2 anti-mouse F(ab') 2 ,
which is highly crossreactive (>80%) with rat F(ab')2 and has been described elsewhere
(12) . The wells were again washed, then cut out individually and the bound radioactivity
measured in a gamma counter.894
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Results
In the DA into PVG rat strain combination, administration of 1 ml of donor
strain whole blood 7 d before renal transplantation produces active enhancement
with prolonged graft survival, whereas unmodified recipients rapidly reject their
grafts within a few days of transplantation . In an initial experiment (during
which contralateral nephrectomy was performed at the time of transplantation),
five transfused allograft recipients all survived for >100 d and blood urea
measurements at day 5 and thereafter weekly remained low (<20 mM) in all
animals . By contrast the individual survival times in eight unmodified allograft
recipients were 7, 7, 7, 7, 7, 8, 8, and 10 d, with a mean day 5 blood urea of 44
mM (range, 32-54 mM), increasing thereafter until death.
Kinetics ofLeukocyte Infiltration
The results of the morphometric analysis of cryostat sections labeled with
MRC OX-1 (leukocyte-common antigen) are shown in Fig . 1 a . Day 1 renal
allografts showed a minimal cellular infiltrate, but thereafter both rejecting DA
kidneys from unmodified PVG recipients and nonrejecting kidneys from trans-
fused recipients showed a progressive mononuclear cell infiltrate . As can be seen,
cellular infiltration occurred more rapidly in the enhanced than in the rejecting
grafts, and day 3 enhanced grafts had a mean percent area leukocyte infiltrate
of 31% (±8%) compared with that of 11% (±3%) in rejecting grafts (p < 0.05) .
However, by day 5, the cellular infiltrate in rejecting grafts had increased rapidly
to reach levels similar to, or in excess of, those seen in day 5 enhanced allografts.
Day 7 rejecting allografts were too severely damaged (frequently they had
undergone complete infarction) for meaningful immunohistologic analysis but
in day 7 enhanced grafts the level of infiltrate was similar to that at day 5.
Enhanced allografts were also examined at day 100 after transplantation (three
grafts studied) and showed only a minimal (<5%) leukocyte infiltrate . Compari-
son of the distribution of the leukocyte infiltrate in rejecting and enhanced grafts
showed a similar pattern . Initially, the infiltrate was predominantly focal and
largely perivascular, and subsequently it progressed to a diffuse interstitial,
peritubular and periglomerular infiltrate but with a notable absence of infiltrat-
ing cells within the glomeruli . In contrast to allografts, DA isografts examined
at days 1, 3, and 5 after transplantation showed only a sparse cellular infiltrate,
which when assessed by morphometric analysis, did not exceed 5% in any of the
grafts examined (results not shown) .
Phenotypic Analysis of the Cellular Infiltrate
Fig . 1 also shows the results of the phenotypic analysis of the cellular infiltrate
in rejecting and enhanced allografts . Serial sections labeled with the different
monoclonal antibodies were assessed by morphometry and the results are ex-
pressed as the percentage area infiltrate for each antibody . Day 3 enhanced
allografts showed a heavier infiltrate ofMRC OX-8+ cells (Tc and most NK cells)
than day 3 rejecting grafts (Fig . 16) but by day 5, the MRC OX-8' infiltrate in
rejecting grafts had increased markedly and was greater than that in day 5
enhanced allografts (21% ± 3% vs . 11 % ± 1%, p < 0.01) . See also Fig . 2A and
B. The percentage area infiltrate in day 7 enhanced grafts was similar to that





Percent labeled cellular infiltrate in normal DA kidney (open bars), in DA renal
allografts from unmodified PVG recipients (hatched bars), and actively enhanced allografts
from transfused recipients (solid bars) . Cryostat sections were labeled with MRC OX-1 (a),
MRCOX-8 (b),W3/25 (c), MRCOX-19 (d),W3/13 (e), andMRC OX-39 (f) . Percent infiltrate
was determined by point counting with a microscope eyepiece graticule . The results are the
mean ± SD of five allografts examined at each time point . Statistical analysis was performed
using the Mann-WhitneyU test .
Both rejecting and enhanced grafts showed a progressive accumulation of
W3/25+ cells (Th and some macrophages) . However, the absolute percent area
infiltrate, which was the same in both rejecting and enhanced allografts (Fig . 1 c)
was consistently less than that observed when corresponding sections were labeled
with MRC OX-8 (see also Fig . 2C and D) . Cryostat sections were also labeled
with a mixture ofMRC OX-8 and W3/25 antibodies . The percent area infiltrate
determined in these sections was very similar to that calculated as the sum of
MRC OX-8+ and W3/25+ cells for each section (results not shown), indicating896 SURV
FIGURE 2 . Immunohistologic studies in rejecting and actively enhanced DA renal allografts
moved at day 5 from PVG recipients . Cryostat sections were labeled with mAbs; using the
operoxidase technique . Sections were lightly counterstained with hematoxylin and
photographed usingagreen filter to enhance the contrast of the peroxiclase reaction product .
All sections X 250 (A) Rejecting and (B) enhanced renal allografts labeled with MRC OX-8 .
Note heavier infiltrate in rejecting graft . (C) Rejecting and (D) enhanced allografts labeled
with W3/25 showing similar levels of infiltration . (E) Rejecting and (F) enhanced allografts
labeled with MRC OX-39 . Note relative absence of IL-2 receptor-positive cells in enhanced
graft .
OF ENHANCED RAT RENAL ALLOGRAFTS
infiltrating cells expressed both the W3/25 and MRC OX-8
I
The percent labeled infiltrate using MRC OX-19 (pan T cell) gave unexpect-
edly low results (Fig . I d) for both rejecting and enhanced allografts, with values
which were far exceeded by the sum ofMRC OX-8' and W3/25' cells. This
discrepancy is undoubtedlydue, at least in part, to thepresence of large numbers
of NIA cells (MRC OX-8', MRC OX-19-) and/or macrophages (W3/25', MRCARMSTRONG ET AL.
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OX-19-) but may also be a result of weakly labeled MRC OX-19' cells, which
were not apparent using the immunoperoxidase staining technique. The pattern
of labeling with W3/13 (T cells, neutrophils, and plasma cells) was similar to, but
greater than that seen for MRC OX-19 (Fig. 1 e).
Staining with MRC OX-39 showed a more rapid appearance ofIL-2 receptor-
positive cells in enhanced grafts (Fig. 1f) but by day 5 the percent area infiltrate
was higher in the rejecting than in enhanced grafts (9% ± 3% vs. 4% ± 1%, p <
0.01). See also Fig. 2E and F.
Cytotoxicity Assays
Graft infiltrating cells and spleen cells were harvested 5 d after renal trans-
plantation andtested for specific and nonspecificcytotoxicity in a 6-hchromium-
release assay. Specific cell lysis was assessed using DA Con A blasts as the target
cells, and Fig. 3a shows the results ofa typicalexperiment. Both graft infiltrating
cells and splenocytes from unmodified recipients demonstrated cytotoxic activity
against the specific target although the levels of lytic activity were modest and,
in the case of graft infiltrating cells, a marked "prozone" effect was commonly
seen. Cells obtained from the graft and spleen of transfused recipients also
demonstrated significant specific cytotoxicity and the levels of lysis seen were
similar to those observed in cells obtained from unmodified recipients. In five
separate experiments the values for specific cytotoxicity produced by splenocytes
from unmodified vs. transfused recipients (at E/T ratio of 100:1) were 18% vs.
16%, 20% vs. 23%, 30% vs. 26%, 19% vs. 22%, and 25% vs. 26%. Similarly,
values for the specific cytotoxicity produced by graft infiltrating cells from
unmodified vs. transfused recipients (at E/T ratio of 50:1) were 22% vs. 15%,
13% vs. 13%, 14% vs. 20%, 17% vs. 29% and 21% vs. 24%. In additional
experiments, in which "third-party" Lewis (RT1') strain Con A blasts were used
as the targets, there was minimal cytotoxic activity, indicating that the cytotoxic
activity against DA Con A blasts was due to alloantigen specific cytotoxic cells
rather than nonspecific effector cells. It was notable that the levels ofalloantigen
specific cytotoxicity observed in the above experiments were consistently lower
(twofold or more) than the levels found in identical experiments carried out on
unmodified renal allograft recipients in other rat strain combinations (e.g., DA
into Lewis [RT11]).
Nonspecific cell lysis was assessed using the rat myeloma Y3 as the target.
Graft infiltrating cells and splenocytes from both unmodified and transfused
recipients showed nonspecific cytotoxicity (Fig. 3b). The levels of lytic activity
were similar in both untreated and transfused recipients and within each exper-
iment were usually greater than those seen against the alloantigen-specific target.
In five separate experiments the values for nonspecific cytotoxicity produced by
splenocytes from unmodified vs. transfused recipients (at E/T ratio of 100:1)
were 32% vs. 40%, 29% vs. 37%, 70% vs. 74%, 30% vs. 39%, and 47% vs. 45%.
Similarly, values for the nonspecific cytotoxicity produced by graft infiltrating
cells from unmodified vs. transfused recipients (at E/T ratio of 100:1) were 15%
vs. 15%, 23% vs. 19%, 25% vs. 22%, 15% vs. 22%, and 30% vs. 26%.
In two experiments, alloantigen specific cytotoxicity and nonspecific cytotox-
icity were examined after depletion of macrophages from the effector cells by898
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FIGURE 3 .
￿
(a) Cytotoxic activity of cells recovered at day 5 from renal allograft (open circles)
and spleen (open triangles) of unmodified recipient and from the renal allograft (solid circles)
and spleen (solid triangles) of transfused recipient, against the alloantigen-specific target (DA
Con A blasts). (b) Nonspecific cytotoxic activity ofcells from day 5 renal allograft (open circles)
and spleen (open triangles) of unmodified recipient and from renal allograft (solid circles) and
spleen (solid triangles) of transfused recipient, against the Y3 rat myeloma target.
incubating them with carbonyl iron powder, at 37'C for 30 min and then
removing the iron particles and phagocytic cells with a strong magnet . This
procedure did not reduce either the alloantigen specific or nonspecific cytotoxic
activity, indicating that the observed cytotoxicity was mediated by lymphocytes .
Class IMHC Antigen Expression
Immunohistology.
￿
Class IMHC expression was detected byimmunoperoxidase
staining with MN4-91-6, which labels DA but not PVG class I antigens (therefore
allowing unequivocal determination of donor class I expression), and also by
MRC OX-18, which labels a monomorphic class I MHC antigen determinant .
The distribution of class I MHC antigens in normal DA kidney (indicated by
labeling with MN4-91-6) is shown in Fig . 4A . There was strong staining of
interstitial areas (including dendritic cells and possibly capillary endothelium)
and arteriolar and venous endothelium, moderate staining of glomeruli, weak
staining of the cortical tubules, and occasional patchy staining of medullary
tubules. The same distribution of class I MHC antigens in normal DA kidney
was also observed with MRC OX-18. DA renal allografts from both unmodified
and transfused PVG recipients (five kidneys from each groupforeach time point
were examined) showed rapid and marked induction of donor class I MHC
antigens on all structures . Increased tubular staining was apparent as early as
day l, and by day 3 both rejecting (Fig . 4B) and enhanced grafts (Fig . 4C)
showed strong staining of all tubular cells and glomeruh . These changespersisted
in day 5 rejecting, day 5 enhanced, and day 7 enhanced allografts . In day 100
enhanced allografts (three kidneys examined), class I MHC expression had
reverted to normal except that the donor strain interstitial staining was not
apparent . When the above sections were labeled with MRC OX-18, a similar
pattern of class I MHC expression was seen, except that, in addition, there wereARMSTRONG ET AL.
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largenumbers ofpositively labeled infiltrating cellsand, in particular, in day 100
enhanced allografts, there was a normal complement ofrecipient strain dendritic
cells (MN4-91-6-, MRC OX-18'). DA isografts examined at days 3, 5, and 7
occasionally showed a slight increase in class I MHC antigen expression on renal
tubular cells, but this was much less intense and more variable than that seen in
rejecting and enhanced allografts.
Quantitative Absorption Analysis.
￿
The kinetics of donor class I MHC antigen
induction inrejectingand enhanced renalallografts were assessed byquantitative
absorption analysis of kidney homogenates using the mAb MN4-91-6. This
analysis confirmed the immunohistologic findings and showed that in both
rejecting and enhanced allografts there was a rapid and substantial increase in
class I MHC antigen expression, which by day 5 was severalfold greater than
that found in normal kidneys. As shown in Fig. 5, the induction ofclass I MHC
antigens occurred more rapidly in enhanced than in rejecting grafts and even by
day 1 enhanced grafts showed a pronounced increase. By day 3 the levels were
similar to those detected only by day 5 in rejecting grafts.
Class 11 MHC Antigen Expression
Immunohistology.
￿
Class II MHC expression was detected by immunoperoxi-
dasestaining with F17-23-2, which labels DAbut not PVG class II MHC antigens,
therefore allowing a precise determination ofdonor class 11 expression, and also
by MRC OX-6 which labels a monomorphic class II MHC antigen determinant
(five kidneys from each group for each time point were examined). The distri-
bution ofclass II MHC antigen in normal DA kidney (indicated by labeling with
F17-23-2) is shown in Fig. 4D. Class II antigen expression was most obvious on
the interstitial dendritic cells scattered throughout the kidney. In addition, there
was weak class II antigen expression by some renal tubules (mostly by the basal
half of cells in the proximal tubules), but there was no evidence of class II
expression by vascular endothelium nor by glomeruli and the surrounding
Bowman's capsule.
By day 1 after transplantation allografts from both unmodified and transfused
recipients showed a slight diminution in the frequency of class II positive
interstitial dendritic cells. Apart from this feature day 1 rejecting allografts were
indistinguishable from normal kidneys, but day 1 enhanced allografts showed a
slight focal increase in donor class II antigen expression on proximal tubules. By
day 3, both rejecting (Fig. 4E) and enhanced (Fig. 4F) grafts showed foci of
increased class II expression and this was most marked in enhanced grafts. In
addition, day 3 enhanced, but not rejecting grafts, showed occasional induction
ofdonor class II antigen on arteriolar endothelium and on Bowman's capsules
as well asa striking reduction in the number ofinterstitial dendritic cells. By day
5, both rejecting (Fig. 4G) and enhanced (Fig. 4H) grafts stained strongly for
donor class II antigen on all tubular cells, arteriolar vascular endothelium, and
Bowman's capsulealthough the glomeruliremained negative. Inaddition, donor-
type (F17-23-2'') interstitial dendritic cells had virtually disappeared and did not
appear to have been replaced by recipient-type dendritic cells (i.e., MRC OX-6'
cells). These changes persisted in day 7 enhanced grafts. By day 100, the donor
class 11 antigen expression on renal tubules had reverted almost to normal and900
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FiGuim 4.
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Immunohistologic studies of class I and class II MHC antigens in normal DA
kidney and in rejecting and actively enhanced DA renal allografts from PVG recipi





Kinetics of donor class I MHC antigen induction in rejecting and actively en-
hancedDA kidneysfromPVG recipients. Quantitative absorption analysis wasperformed with
the MN4-91-6 antibody, which was absorbed with tripling dilutions of kidney homogenate .
Residual antibody was assayed by incubating with DA RBC and detecting binding with "'I-
labeled sheep anti-mouse .
only occasional expression ofdonor class II MHC antigen on arteriolar vascular
endothelium was apparent . The day 100 enhanced allografts contained a normal
complement of interstitial dendritic cells that expressed only recipient-type class
II antigen (i.e ., were F17-23-2- but MRC OX-6+) . None of the DA isografts




The kinetics of donor class If MHC antigen
induction in rejecting and enhanced allografts were assessed by quantitative
absorption analysis using polyspecific PVG anti-DA spleen serum as the source
of antibody, and microtiter plates coated with purified DA class 11 antigen as the
target . This analysis (Fig. 6) confirmed the immunohistologic findings and
showed that donor class lI MHC induction occurred more rapidly in the en-
hanced than in the rejecting renal allografts . By day 1 after transplantation
C) and F17-23-2 against donor class II MHCantigens (D-H) using the immunoperoxidase technique .
All sections X 160 . (A) Normal DA kidney labeled with MN4-91-6 antibody . Note strong staining of
interstitial cells and vascular endothelium, moderate staining of glomerulus and weak staining of
tubules . (B) Rejectingand (C) enhanced renal allografts 3 dafter transplantation labeled with MN4-
91-6 . Note increased staining of tubules and a decrease in C ofpositively stained interstitial cells. (D)
Normal DA kidney labeled with F17-23-2 . Note strong staining of interstitial dendritic cells, weak
staining of some proximal tubules, and lack of staining of vascular endothelium (arrow) . (E) Rejecting
and (F) enhanced renal allografts 3 d after transplantation labeled with F17-23-2 antibody . Note
increased staining of tubules (moremarked in enhanced graft) and staining of arteriolar endothelium
(arrow) in enhanced graft . (G) Rejectingand (M enhanced allografts 5 d after transplantation labeled
with F17-23-2 antibody . Note heavy staining of all tubular cells in the absence ofstaining of the large
number of host infiltrating cells . Arteriolar endothelium is positively stained (arrows) but glomeruli
(excepting Bowmans capsule) remain negative (arrowheads) and there are very few positively stained
interstitial cells. In all experiments, labeling with MRCOX-21 (mouse anti-human Cab inactivator)
wascompletely negative .002
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FIGURE 6.
￿
Kinetics of donor class II MHC antigen induction in rejecting and actively
enhanced DA kidneys from PVG recipients . PVG anti-DA serum was absorbed with tripling
dilutions ofthe kidney homogenates. Residual antibody was assayed by incubating the absorbed
serumonPVC microtitre plates to which ure class II MHCantigens had been bound . Binding
of the alloantiserum was detected with 's I-labeled rabbit anti-mouse .
rejecting allografts showed a reduction in class II MHC antigen expression
whereas enhanced allografts showed levels similar to those in normal kidney .
Thismay be explained by a reduction in the number of interstitial dendritic cells
in both rejecting and enhanced allografts (inasmuch as these cells make up a
large proportion of class II positive structures in the normal kidney), which in
the case of day 1 enhanced grafts is compensated for by the rapid induction of
class II antigen on renal tubular cells . By day 3 the expression of class II in
rejecting allografts had increased to levels slightly greater than those in normal
kidney . By contrast, day 3 enhanced allografts showed a marked increase in class
II induction, with levels similar to those subsequently seen in day 5 rejecting
grafts . There was no further increase in class II expression by day 7 in either
enhanced or rejecting grafts (data not shown) .
Discussion
The prolonged survival ofMHC incompatible organ grafts, achieved by prior
administration of donor antigen, depends on several factors that include the
strain combination, the type of organ transplanted, and the nature, dose and
timing of the antigen pretreatment (2, 32, 33) . We have shown in this report
that, although a single preoperative transfusion ofdonor strain blood markedly
prolongs rat renal allograft survival, there is an accelerated immunological
response to the graft which is characterized by early loss of graft dendritic cells,
rapid and substantial leukocyte infiltration, alloantigen-specific and -nonspecific
cytotoxic activity, and unexpectedly, an accelerated and striking increase of
donorstrain class I and class II MHC antigen expression within the graft . These
findings are of relevance to both the process of renal allograft rejection and to
an understanding of the induction phase of active enhancement .ARMSTRONG ET AL.
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Bone marrow-derived interstitial cells (passenger leukocytes) are highly im-
munogenic components of organ allografts and are generally considered to be
important initiators of the rejection response (7, 34, 35). The disappearance of
donor interstitial dendritic cells from rejecting and enhanced renal allografts
may have been due to either destruction in situ or migration from the graft. The
more rapid disappearance of dendritic cells from enhanced grafts corresponded
with, and possibly initiated, the accelerated leukocyte infiltrate, the composition
of which was similar to that seen in rejecting grafts, with the notable exception
thatenhanced grafts containeda reduced numberofMRC OX-8+ cells and MRC
OX-39+ cells. Whether this reflected important differences in the proportions
of functionally diverse MRC OX-8+ cells in rejecting and enhanced grafts is not
clear from the present study but the increased number of IL-2 receptor-positive
cells suggests a greater degree ofcellular activation in rejecting grafts.
The striking induction of class I and class II MHC antigens in rejecting
allografts is widely reported (12, 25, 36, 37). However, the accelerated and
substantial increase in not only class I but also class II MHC antigens in enhanced
allografts was surprising. It is of particular interest because increased expression
of class I and class II MHC antigens may, in principle, contribute to rejection
both by activating the rejection responses and by making target cells more
susceptible to them. In particular, specific cytotoxic Tcell lysis directed prefer-
entially at class I MHC targets (38) may be augmented by increased expression
of class I antigens whereas DTH responses and the action of Th cells, directed
primarily at class II targets, may be augmented by increased expression of class
II MHC antigens (39, 40). Because the induction of class II MHC antigens is
almost certainly mediated by IFN-y (13, 14) and other lymphokines released
from activated graft infiltrating cells, it might be expected that an effective
immunosuppressive regimen would prevent class II induction. This suggestion
is supported by the recent report that nonrejecting rat renal allografts in
cyclosporin-treated recipients showed diminished induction of class I and no
induction of class II MHC antigens (41). The findings in the present study
therefore suggest that there are, within the enhanced grafts, activated T cells,
which have differentiated to the stage of secreting lymphokines such as IFN-y
but which are unable to mediate effective graft damage. Ifthe accelerated MHC
induction in enhanced grafts does, as seems likely, increase their vulnerability to
rejection, it is clearly insufficient to overcome the protective mechanisms that
are initiated during enhancement. Moreover, the accelerated MHC induction
may be a necessary component of the early phase of enhancement which, after
prior transfusion, provides the appropriate signal for induction of suppressor
mechanisms.
The observation that spleen cells and graft infiltrating cells from both trans-
fused and untreated recipients showed similar levels of cytotoxic activity against
NK-sensitive targets is consistent with the consensus that nonspecific cytotoxic
effector cells do not play a major role in graft rejection (3, 29). However, the
finding that unmodified and transfused graft recipients also showed similar levels
of alloantigen-specific cytotoxicity was surprising. Assuming that the in vitro
cytotoxicity assay is an appropriate indication ofcytolytic activity within the graft
this suggests that either specific cellular cytotoxicity is not the predominant904
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mechanism of graft destruction in the DA into PVG strain or that the observed
Tc activity is effectively suppressed within the graft. Interestingly, the levels of
alloantigen-specific cytotoxicity were lower than those seen in other rat strain
combinations (e.g., DA into Lewis) under identical conditions, which may be
attributable in part to Ir gene control and the "low responder" status of PVG
recipients to this aspect of the alloimmune response (42, 43). Nevertheless,
unmodified PVG recipients reject DA renal allografts in times comparable to
otherrecipient strains, raising the possibility thatadditional mechanisms, notably
DTH, play a significant role in the rejection response in this strain combination.
Irrespective of the mechanism of graft rejection, however, the present study
emphasizes the overwhelming suppressive effect of preoperative donor blood
transfusion despite the presence ofboth large numbers ofpotential effector cells
and increased target antigen expression within the graft.
Summary
Administration of 1 ml ofdonor whole blood 7 d before renal transplantation
produces long-term (>100 d) graft survival in the DA (RTI') into PVG (RT1`)
rat strain combination. Using this model, the pattern and phenotype ofinfiltrat-
ing leukocytes were examined in rejecting and enhanced renal allografts, at days
1, 3, 5, and 7 after transplantation, by immunohistologic techniques. Paradoxi-
cally, enhanced grafts showed a more rapid and substantial leukocyte infiltrate,
the phenotype ofwhich was similarto thatin rejecting grafts except fora reduced
number ofMRC OX-8' cells and MRC OX-39+ cells. Graft infiltrating cells and
splenocytes from transfused animals showed similar, although modest, levels of
both nonspecific cytotoxicity and alloantigen-specific cytotoxicity. Immunohis-
tologic analysis of MHC antigen distribution within the allograft revealed,
unexpectedly, that enhanced grafts underwent an accelerated and extensive
induction of both donor class I and class II MHC antigens. These findings were
confirmed by allospecific quantitative absorption analysis, which showed sever-
alfold increases in class I and class II MHC antigens by day 3 in enhanced grafts
but not until day 5 in rejecting grafts. An additional observation was the more
rapid disappearance of donor interstitial cells from enhanced grafts. These
findings emphasize the overwhelming suppressive effect induced by an organ
allograft after preoperative blood transfusion despite the associated induction of
large numbers of potential effector cells and increased target antigen density
within the graft.
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